Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 11, 2019 / 04:20PM GMT
Release Date Price: $131.32 (+0.56%)
Robert Patrick Jones
Goldman Sachs Group Inc., Research Division - VP

All right. Good morning, everyone. Welcome to the Charles River session. I'm Bob Jones, and I cover the CROs here at Goldman. Very pleased to introduce Charles River, as you're all well aware, a leading preclinical CRO.

I am joined on stage by David Smith, EVP and CFO of Charles River. David joined in 2014 and was named CFO and EVP of the company in August of 2015. So welcome, David.

David Ross Smith
Charles River Laboratories International, Inc. - Corporate Executive VP & CFO

Thank you.

Questions & Answers

Robert Patrick Jones
Goldman Sachs Group Inc., Research Division - VP

So I guess we'll just jump right in. I think everybody knows the format. To the extent that you have a question, feel free to raise your hand, we'll get you a microphone.

But I thought for starters, David, good place to begin would just be around biotech funding. I think it's been a pretty incredible innovation cycle, I think most would

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot